Meso & Beyond Medical Center is categorized under Medical Centers in Fuquay Varina, NC and active since 2010.
Meso & Beyond Medical Center was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 6221100 by the NAICS.
If you are seeking more information, feel free to contact Gloria Brooks at the company’s single location by writing to 1000 North Main St # 100, Fuquay Varina, North Carolina NC 27526 or by phoning (919) 285-4373. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Meso & Beyond Medical Center |
| Contact Person: | Gloria Brooks |
| Address: | 1000 North Main St # 100, Fuquay Varina, North Carolina 27526 |
| Phone Number: | (919) 285-4373 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 6221100 |
| Share This Business: |
Meso & Beyond Medical Center was started in 2010 to provide professional Medical Centers under the SIC code 8011 and NAICS code 6221100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Gloria Brooks for inquiries that concern Meso & Beyond Medical Center by calling the company number (919) 285-4373, as your correspondence is most welcome. Additionally, the physical location of the single location of Meso & Beyond Medical Center can be found at the coordinates 35.59174,-78.78483 as well as the street address 1000 North Main St # 100 in Fuquay Varina, North Carolina 27526.
For its online presence, you may visit Meso & Beyond Medical Center’s website at and engage with its social media outlets through on Twitter and on Facebook.